News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Merck, Pfizer to jointly develop diabetes drug

Started by riky, April 30, 2013, 09:00:21 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Merck, Pfizer to jointly develop diabetes drug

<p><a href="http://news.yahoo.com/merck-pfizer-jointly-develop-diabetes-drug-120154878.html"><img src="http://l.yimg.com/bt/api/res/1.2/efdmeuxRj.4Psu4.GxFqfw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-04-29T182025Z_1_CBRE93S0XFC00_RTROPTP_2_SCHERINGPLOUGH-MERCK.JPG" width="130" height="86" alt="A view of the Merck &amp; Co. campus in Linden, New Jersey" align="left" title="A view of the Merck &amp; Co. campus in Linden, New Jersey" border="0" /></a>By Ransdell Pierson (Reuters) - Pfizer Inc and Merck &amp; Co Inc said they will co-develop Pfizer's experimental type 2 diabetes drug ertugliflozin, both as a standalone product and in combination with other drugs, including Merck's blockbuster Januvia. The Pfizer medicine belongs to a new class of diabetes treatments called SGLT2 inhibitors. Now nearing Phase III late-stage trials, it is behind similar drugs in development -- including Johnson &amp; Johnson's Invokana (canagliflozin) which was approved by U.S. regulators in late March. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login